Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.16 USD | -6.65% | -7.25% | 0.00% |
May. 21 | Alto Neuroscience, Inc. Appoints Michael Hanley as Chief Operating Officer | CI |
May. 14 | Alto Neuroscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 321M | |
+48.82% | 54.63B | |
-6.29% | 39.92B | |
+37.07% | 38.82B | |
+14.05% | 26.86B | |
-11.17% | 26.22B | |
-21.64% | 18.78B | |
+25.87% | 12.21B | |
+0.97% | 12.16B | |
+26.18% | 11.94B |
- Stock Market
- Equities
- ANRO Stock
- News Alto Neuroscience, Inc.
- Jefferies Initiates Alto Neuroscience With Buy Rating, Price Target is $33